Cancer Research Institute
New York, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Cancer Research Institute to Honor Leaders in Cancer Immunotherapy

The Cancer Research Institute announced today the winners of the 2015 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research. This annual award recognizes the contributions of individuals, corporations, and foundations that...
10-Aug-2015 9:05 AM EDT Add to Favorites

Cancer Research Institute to Honor Outstanding Contributions to Basic and Tumor Immunology Research

The Cancer Research Institute will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy. The award ceremony will take place at the Institute’s 29th Annual Awards...
10-Aug-2015 6:00 AM EDT Add to Favorites

Cancer Research Institute Awards $29.3 Million in Grants to Advance Immune-Based Treatments for Cancer

The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced that it has committed more than $29.3 million in new funds to accelerate cancer...
4-Aug-2015 10:00 AM EDT Add to Favorites

Immunotherapy: 5 Ways to Stop Cancer

"Immunotherapy: 5 Ways to Stop Cancer" features five 1-minute animated videos that provide a quick overview of the five most common immunotherapies in use: monoclonal antibodies, checkpoint inhibitors, cancer vaccines, adoptive cell therapy, and...
30-Jul-2015 9:05 AM EDT Add to Favorites

What Cancer Patients Should Know: Latest Immunotherapy News From ASCO

Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer types.
30-Jul-2015 9:05 AM EDT Add to Favorites

Cancer Research Institute Celebrates Third Annual Cancer Immunotherapy Month™ in June

Cancer immunotherapy, which is designed to empower a patient’s own immune system to eliminate cancer cells anywhere in the body, has produced cure-like remissions in very advanced cancers, including melanoma, lung cancer, and leukemia.
4-Jun-2015 1:05 PM EDT Add to Favorites

TheAnswerToCancer.org Website for Patients and Caregivers Expands Functionality

The Cancer Research Institute (CRI) is proud to announce the addition of peer-to-peer advocacy, enhanced sharing functionality, and tumor type-specific information to TheAnswerToCancer.org (TheA2C), a first-of-its-kind website and online community...
3-Nov-2014 11:15 AM EST Add to Favorites

Cancer Research Institute to Host 22nd Annual Cancer Immunotherapy Symposium

The Cancer Research Institute (CRI) will host its 22nd Annual International Cancer Immunotherapy Symposium October 6-8, 2014, at The Grand Hyatt in New York City.
3-Oct-2014 6:05 PM EDT Add to Favorites

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

Our YouTube Videos